We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock
CDMO

Delisted

CDMO was delisted on the 4th of February, 2025.

Back to rankings

174 hedge funds and large institutions have $381M invested in Avid Bioservices, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 58 increasing their positions, 50 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $218K | Put options by funds: $82K

16% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 50

13% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 39

2% more funds holding

Funds holding: 170 → 174 (+4)

36% less capital invested

Capital invested by funds: $591M → $381M (-$210M)

Holders
174
Holders Change
+4
Holders Change %
+2.35%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
58
Reduced
50
Closed
39
Calls
$218K
Puts
$82K
Net Calls
+$136K
Net Calls Change
+$127K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$26.9M
2
Morgan Stanley
Morgan Stanley
New York
+$7.16M
3
State Street
State Street
Massachusetts
+$6.76M
4
Two Sigma Investments
Two Sigma Investments
New York
+$3.46M
5
2C
272 Capital
Texas
+$3.02M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$28.3M
2
GCM
Geneva Capital Management
Wisconsin
-$21.3M
3
Artisan Partners
Artisan Partners
Wisconsin
-$15.8M
4
RIM
Ranger Investment Management
Texas
-$14.7M
5
Jennison Associates
Jennison Associates
New York
-$14M
Name Holding Trade Value Shares
Change 		Change in
Stake
QCG
151
Quadrant Capital Group
Ohio
$3.21K +$2.94K +456 +1,200%
AF
152
Allworth Financial
California
$2.96K +$2.75K +426 +1,469%
S
153
SignatureFD
Georgia
$2.54K +$2.52K +391 New
GWSG
154
GPS Wealth Strategies Group
Colorado
$1.95K – – –
PA
155
Pineridge Advisors
Missouri
$1.68K +$1.66K +258 New
LC
156
Lindbrook Capital
California
$1.56K +$1.55K +240 New
HNB
157
Huntington National Bank
Ohio
$1.55K +$1.54K +239 New
PWMG
158
Private Wealth Management Group
New Jersey
$1.14K +$1.13K +176 New
GI
159
GAMMA Investing
California
$1.07K +$1.02K +158 New
AA
160
Addison Advisors
Vermont
$1.03K – – –
SO
161
STRS Ohio
Ohio
$1K – – –
GWS
162
Glassman Wealth Services
Virginia
$858 +$851 +132 New
VCM
163
Versant Capital Management
Arizona
$546 -$1.6K -249 -75%
Allspring Global Investments
164
Allspring Global Investments
North Carolina
$539 -$18.5K -2,874 -97%
LFG
165
Larson Financial Group
Missouri
$468 +$464 +72 New
FFA
166
Farther Finance Advisors
California
$364 +$361 +56 New
ASN
167
Advisory Services Network
Georgia
$325 +$322 +50 New
AF
168
Advisornet Financial
Minnesota
$215 +$213 +33 New
KWAG
169
Kiely Wealth Advisory Group
North Carolina
$206 +$187 +29 New
CPG
170
Cornerstone Planning Group
New Jersey
$98 – – –
LOIP
171
Live Oak Investment Partners
Texas
$98 – – –
TWC
172
TD Waterhouse Canada
Ontario, Canada
$83 – – –
HCM
173
Hollencrest Capital Management
California
$52 – – –
HI
174
Harbour Investments
Wisconsin
$46 – – –
GCM
175
Geneva Capital Management
Wisconsin
– -$21.3M -2,258,671 Closed
5 6
7
8 9

CDMO Hedge Fund Activity: Q4 2023 in Review

174 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2023, worth a combined $381M — down 36% from $591M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new CDMO positions and 39 closed out — a net gain of 5 holders — while 58 added to existing stakes and 50 trimmed.

The largest buyer was Millennium Management, adding an estimated $26.9M. The largest seller was BlackRock, cutting an estimated $28.3M.

  • 174 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2023, up from 170 in Q3 2023.
  • Funds reported $381M of Avid Bioservices, Inc. Common Stock stock for Q4 2023, down 36% quarter-over-quarter.
  • 44 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2023 and 39 closed out, a net change of +5 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2023 was Millennium Management, an estimated $26.9M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q4 2023 was BlackRock, an estimated $28.3M sold.

Based on aggregated 13F filings for Q4 2023.